Major Depressive Disorder. Major depressive disorder, single episode, mild
Conditions
Interventions
Intervention 1: control group: Patients received 2 oral capsules/day containing 15 mg of Crocin for 6 consecutive weeks. Crosin is a carotenoid that is extracted and purified from saffron that made a
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Having diagnostic criteria for depression Patient consent to participate in the study
Exclusion criteria
Exclusion criteria: Those who are psychotic. Those who had thoughts or attempted suicide in the past or present. Those who have substance abuse. Those with recurrent depression Those whose recent episodes are severe
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression Score. Timepoint: At the beginning (before intervention), on third week of study and the sixth week after intervention. Method of measurement: Hamilton Depression Rating Scale.;Anxiety Score. Timepoint: At the beginning, on third week of study and the sixth week after intervention. Method of measurement: Hamilton Anxiety Rating Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Therapeutic Effect Score. Timepoint: The timing of measuring the therapeutic effect as secondary outcome in third week and 6th week after using Crocin and Serteralin pills. Method of measurement: Clinical Global Improvement Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactTalaei Ali
Mashhad University of Medical Sciences
Outcome results
None listed